In a report released today, Tim Anderson from Bank of America Securities maintained a Sell rating on Moderna (MRNA – Research Report), with a price target of $26.00. The company ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.